# Dixon Investments Inc – FDA Inspection, Mar 11, 2025

Source: https://www.keypedia.com/records/fda_inspections/dixon-investments-inc/91961a19-5a06-4d00-8690-898dde318914
Source feed: FDA_Inspections

> FDA inspection 1263416 of Dixon Investments Inc, March 11, 2025. Classification: Official Action Indicated (OAI). 7 citations under 21 CFR part 211. Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1263416
- Company Name: Dixon Investments Inc
- Inspection Date: 2025-03-11
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Atlanta District Office
- Citation Count: 7

## Related Documents

- [FDA Inspection 1083739 - 2019-03-22](https://www.keypedia.com/records/fda_inspections/dixon-investments-inc/bfeaee93-1a4b-4ff0-af85-cc713247e533)
- FDA Inspection 956550 - 2015-12-16
- FDA Inspection 858354 - 2013-12-06
- [FDA Inspection 758691 - 2011-12-13](https://www.keypedia.com/records/fda_inspections/dixon-investments-inc/9d05781a-caf8-419b-8614-1059df6ebac8)
- [FDA Inspection 646629 - 2010-01-25](https://www.keypedia.com/records/fda_inspections/dixon-investments-inc/fedfc68f-e4c9-4dc3-b464-bd6017ec6349)

## Related Officers

- [Investigator](https://www.keypedia.com/people/samantha-e-cleek/7305f28f-9c92-427d-86ec-42c0bb6bf3ce)

Company: https://www.keypedia.com/companies/dixon-investments-inc/ce191609-e6f1-4391-8f04-21996703095d

Office: https://www.keypedia.com/offices/atlanta-district-office/7586d99a-288e-49d1-8c3d-d88b7354b7a7